Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day
Inovio Pharmaceuticals Inc. closed $12.79 short of its 52-week high ($14.75), which the company achieved on April 1st.
Catalyst Watch: CES, M&A votes and the Supreme Court tackles the TikTok case
Stay informed with Seeking Alpha's Catalyst Watch - a breakdown of upcoming events impacting stock prices next week.
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
Inovio Pharmaceuticals Inc. closed $12.93 below its 52-week high ($14.75), which the company achieved on April 1st.
Zacks.com on MSN3d
PGEN Stock Surges More Than 40% in a Week: What's Driving the Rally?
Shares of Precigen PGEN have soared nearly 43% in the past week after the company provided an encouraging regulatory update ...
Australian Broadcasting Corporation4d
Stock Market
Foxtel sold for $3.4 billion to a British streaming outfit, while the ASX 200 gained 1.7 per cent, recouping much of last week's losses. Here's how the day's trade unfolded, with insights from our ...
State Street Corp Grows Position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO)
State Street Corp raised its position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) by 11.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 490,662 ...
Inovalis REIT: Insider Buys Step Up As Stock Trades At 14% Of Book Value
Inovalis REIT is an intriguing speculative opportunity. It's had a horrible past few years of performance and is now a penny ...